| 中文名 | 达帕菲尼中间体 |
|---|---|
| 英文名 | N-{3-[5-(2-chloro-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide |
| 中文别名 |
甲磺酸达拉非尼中间体
N-{3-[5-(2-氯-4-啶基)-2-(1,1-二甲基乙基)-1,3-噻唑-4-基]-2-氟苯基}-2,6-二氟苯磺酰胺 达拉非尼中间体N-1 达拉菲尼中间体5 达拉非尼 N-1 达帕菲尼杂质2 |
| 英文别名 |
N-(3-(2-(tert-butyl)-5-(2-chloropyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
N-{3-[5-(2-chloro-4-pyriMidinyl)-2-(1,1-diethylethyl)-1,3-thiazol-4-yl]-2-fluoraphenyl}-2,6-difluorobenzenesulfonaMide N-{3-[5-(2-Chloro-4-pyrimidinyl)-2-(2-methyl-2-propanyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide N-[3-[5-(2-Chloro-4-pyrimidinyl)-2-(1,1-dimethylethyl )-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesul fonamide Dabrafenib Impurity 2 Benzenesulfonamide, N-[3-[5-(2-chloro-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro N-{3-[5-(2-chloro-4-pyriMidinyl)-2-(1,1-diMethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonaMide |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 635.5±65.0 °C at 760 mmHg |
| 分子式 | C23H18ClF3N4O2S2 |
| 分子量 | 538.993 |
| 闪点 | 338.1±34.3 °C |
| 精确质量 | 538.051208 |
| PSA | 121.46000 |
| LogP | 4.12 |
| 蒸汽压 | 0.0±1.9 mmHg at 25°C |
| 折射率 | 1.613 |
| 储存条件 | 2-8°C,保存于惰性气体中 |
|
~%
1195768-23-0 |
| 文献:GLAXOSMITHKLINE LLC; DUMBLE, Melissa; KUMAR, Rakesh; LAQUERRE, Sylvie; LEBOWITZ, Peter Patent: WO2011/47238 A1, 2011 ; |
|
~%
1195768-23-0 |
| 文献:Rheault, Tara R.; Stellwagen, John C.; Adjabeng, George M.; Hornberger, Keith R.; Petrov, Kimberly G.; Waterson, Alex G.; Dickerson, Scott H.; Mook, Robert A.; Laquerre, Sylvie G.; King, Alastair J.; Rossanese, Olivia W.; Arnone, Marc R.; Smitheman, Kimberly N.; Kane-Carson, Laurie S.; Han, Chao; Moorthy, Ganesh S.; Moss, Katherine G.; Uehling, David E. ACS Medicinal Chemistry Letters, 2013 , vol. 4, # 3 p. 358 - 362 |
| 上游产品 2 | |
|---|---|
| 下游产品 2 | |